Ajanta Pharmaceuticals Q4 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,001.8
41.50 (1.40%)
41.50 (1.40%)Volume8.27 K
Updated: Mon 25 Nov, 2024 | 15:56:58
NSE
2,996.736.65 (1.24%)
36.65 (1.24%)Volume1.35 L
Updated: Mon 25 Nov, 2024 | 15:44:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,054.08 | 971.77 | -% | 881.84 | -% |
| Selling/ General/ Admin Expenses Total | 233.51 | 192.42 | -% | 223.64 | -% |
| Depreciation/ Amortization | 34.25 | 33.30 | -% | 33.02 | -% |
| Other Operating Expenses Total | 277.87 | 303.48 | -% | 221.70 | -% |
| Total Operating Expense | 810.01 | 798.53 | -% | 719.26 | -% |
| Operating Income | 244.07 | 173.24 | -% | 162.58 | -% |
| Net Income Before Taxes | 278.04 | 168.34 | -% | 152.05 | -% |
| Net Income | 202.72 | 134.51 | -% | 122.25 | -% |
| Diluted Normalized EPS | 16.09 | 10.50 | -% | 9.54 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST